Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 6, 2014, Pages 545-550

  Busse, Stefan ^a   Busse, Mandy ^b   Brix, Britta ^c   Probst, Christian ^c   Genz, Axel ^a   Bogerts, Bernhard ^a,d   Stoecker, Winfried ^c   Steiner, Johann ^a,d,e  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Institute for Experimental Immunology   (Germany)

^d Center for Behavioral Brain Sciences   (Germany)

^e PEMBROKE COLLEGE   (United Kingdom)

Author keywords

Aging; Alzheimer's disease (AD); NMDA receptor autoantibodies; Psychosis; Subcortical ischemic vascular dementia (SIVD)

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR AUTOANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

AGED; AGING; ALZHEIMER DISEASE; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PSYCHOSIS; SEROPREVALENCE; SUBCORTICAL ISCHEMIC VASCULAR DEMENTIA; ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CHILD; COMPLICATION; GERMANY; IMMUNOLOGY; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PSYCHOTIC DISORDERS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEMENTIA; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; YOUNG ADULT;

EID: 84906934651     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0493-9     Document Type: Article

References (33)

1. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6):413-426 (Pubitemid 46789232)
2. Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D, Yamaguchi S, Kawabata S, Okada M (1998) Glutamate receptors: brain function and signal transduction. Brain Res 26(2-3):230-235 (Pubitemid 28318078)
3. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviours related to schizophrenia. Cell 98(4):427-436 (Pubitemid 29402481)
4. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (New York, NY) 297(5580):353-356 (Pubitemid 34790756)
5. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (New York, NY) 316(5825):750-754 (Pubitemid 46717684)
6. Ulas J, Cotman CW (1997) Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of alzheimer brain. Neuroscience 79(4):973-982 (Pubitemid 27293751)
7. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1(7):426-436 (Pubitemid 37159153)
8. Jagust W (2001) Untangling vascular dementia. Lancet 358(9299):2097-2098
9. de la Torre-Laviana FJ, Moniche-Alvarez F, Palomino-Garcia A, Cayuela-Dominguez A, Vigil E, Jimenez MD (2010) False diagnoses of strokes in emergency departments. Rev Neurol 50(8):463-469
10. de la Torre JC (2010) The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis 7(1-3):116-121
11. Fassbender K, Bertsch T, Mielke O, Muhlhauser F, Hennerici M (1999) Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 30(8):1647-1650 (Pubitemid 29379618)
12. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21(3):383-421 (Pubitemid 30349107)
13. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12(9):1005-1015
14. Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE (1998) Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol 8(1):65-72 (Pubitemid 28055765)
15. D'Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specific plaque types in the alzheimer disease brain. Neurobiol Aging 25(5):675-683 (Pubitemid 38686491)
16. Ting KK, Brew BJ, Guillemin GJ (2009) Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J Neuroinflammation 6(1):36
17. Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol Appl Neurobiol 31(4):395-404 (Pubitemid 41059860)
18. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kastner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA psychiatry 70(3):271-278
19. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091-1098
20. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, Siren AL, Pardo LA, Sperling S, Mohd Jofrry S, Gurvich A, Jensen N, Ostmeier K, Luhder F, Probst C, Martens H, Gillis M, Saher G, Assogna F, Spalletta G, Stocker W, Schulz TF, Nave KA, Ehrenreich H (2013) Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry
21. Mittal VA, Walker EF (2011) Diagnostic and statistical manual of mental disorders. Psychiatry Res 189(1):158-159
22. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231(1-2):86-91
23. Stöcker W (1985) Rationelle histochemie mit einer neuen mikroanalysemethode. Acta Histochem 31:269-281
24. Probst C, Komorowski L, Dähnich C, Rosemann A, Schlumberger W, Wandinger KP, Mothes T, Stöcker W (2007) Designer antigens as diagnostic targets for (auto)antibody determination. From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies Pabst Science Publisher 5:619-632
25. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet neurol 10(1):63-74
26. Pruss H, Finke C, Holtje M, Hofmann J, Klingbeil C, Probst C, Borowski K, Ahnert-Hilger G, Harms L, Schwab JM, Ploner CJ, Komorowski L, Stoecker W, Dalmau J, Wandinger KP (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72(6):902-911
27. Pruss H, Holtje M, Maier N, Gomez A, Buchert R, Harms L, Ahnert-Hilger G, Schmitz D, Terborg C, Kopp U, Klingbeil C, Probst C, Kohler S, Schwab JM, Stoecker W, Dalmau J, Wandinger KP (2012) IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 78(22):1743-1753
28. Harris JA, Devidze N, Halabisky B, Lo I, Thwin MT, Yu GQ, Bredesen DE, Masliah E, Mucke L (2010) Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci 30(1):372-381
29. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) App processing and synaptic function. Neuron 37(6):925-937 (Pubitemid 36398299)
30. Lanz TA, Carter DB, Merchant KM (2003) Dendritic spine loss in the hippocampus of young PDAPP and tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13(3):246-253 (Pubitemid 36937206)
31. Shrestha BR, Vitolo OV, Joshi P, Lordkipanidze T, Shelanski M, Dunaevsky A (2006) Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol Cell Neurosci 33(3):274-282 (Pubitemid 44696319)
32. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27(11):2866-2875 (Pubitemid 46438992)
33. Calabrese B, Shaked GM, Tabarean IV, Braga J, Koo EH, Halpain S (2007) Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 35(2):183-193 (Pubitemid 46843559)